BiondVax to Present at BIO-Europe Spring
<!-- Name:DistributionId Value:8790089 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
BiondVax
BiondVax Presenting at BIO CEO & Investor Conference
<!-- Name:DistributionId Value:8741991 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
BiondVax CEO Issues Letter to Shareholders
JERUSALEM, Dec. 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing, manufacturing and…
IBN Announces Latest Episode of The Stock2Me Podcast featuring Amir Reichman, CEO of…
LOS ANGELES, Dec. 13, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is…
BiondVax reports successful results in preclinical in vivo study of its innovative…
Hamsters infected with SARS-COV-2 and then treated with inhaled anti-COVID-19 NanoAbs demonstrated significantly less severe illness and faster recovery in comparison to infected hamsters…